MedTrace Logo

European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)

NCT04190849 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2022-03-04

No results posted yet for this study

Summary

The EU-PNAFLD (The European Paediatric NALFD Registry) will be a network composed of European centres involved in the care of children with NAFLD, and will include Hepatologists, Endocrinologists, and Scientists, supported by relevant international specialists. This collaboration will build on existing infrastructure (local databases and bio-repositories) and will align with the adult European NAFLD Registry ("EPoS", Elucidating Pathways of Steatohepatitis study) to allow long-term follow-up supported by translational studies. Through an international, well-characterised large-scale cohort, we hope to: facilitate multi-centre clinical trials; extend our understanding of the key disease mechanisms of NAFLD; and establish the natural history of paediatric NAFLD.

Conditions

  • Non-Alcoholic Fatty Liver Disease
  • Non-alcoholic Fatty Liver
  • Non-alcoholic Steatohepatitis

Sponsors & Collaborators

  • The European Association for the Study of the Liver

    collaborator UNKNOWN

  • Children's Liver Disease Foundation

    collaborator UNKNOWN

  • Cambridge University Hospitals NHS Foundation Trust

    lead OTHER

Principal Investigators

  • David B Savage · University of Cambridge

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-14
Primary Completion
2047-11-30
Completion
2047-11-30

Countries

  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04190849 on ClinicalTrials.gov